Upload Avatar (500 x 500)
Jingyu Chen
jchen2022@scu.edu.cn
English, Chinese
Sichuan
Sichuan University
West China Institute of Basic Medicine and Forensic Medicine
  • 2013-2017 PhD: University of Edinburgh
  • National Overseas Talent Introduction Project
  • Sichuan Province High-Level Young Talent Project
  • Chengdu 'Rongpiao Talent Plan'
  • Sichuan Provincial Health Commission 'Health Talent Plan'
  • Sichuan University 'Double Hundred Talent Project' selectee
  • 2017-2022 - University of Cambridge - Postdoctoral Researcher, Associate Researcher
  • 2022-present - Sichuan University - Distinguished Researcher
  • Terry Hamblin Prize from the British Leukemia Research Association
  • Guiding Teacher for the 10th National Undergraduate Basic Medical Innovation Research and Experimental Design Forum National Finals Gold Award (2024)
  • Guiding Teacher for the 10th National Undergraduate Basic Medical Innovation Research and Experimental Design Forum National Finals Bronze Award (2024)
Molecular mechanisms of cancer treatment and prognosis
Mechanisms of hematological tumor development and drug resistance
Nucleolar stress and cellular homeostasis regulation mechanisms
  • ZAP-70 augments tonic B-cell receptor and CCR7 signaling in IGHV–unmutated chronic lymphocytic leukemia., Jingyu Chen*; Vijitha Sathiaseelan; Ingo Ringshausen*, et.al, 2024
  • ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia., Jingyu Chen; Vijitha Sathiaseelan; Ingo Ringshausen*, et.al, 2021
  • Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance., Eugene Park#;Jingyu Chen#; Andrew Moore#; Ingo Ringshausen* et.al, 2020
  • Identification of a novel TIF-IA–NF-κB nucleolar stress response pathway., Jingyu Chen; Lesley A Stark*,et.al, 2018
  • Insights into the Relationship between Nucleolar Stress and the NF-κB Pathway., Jingyu Chen; Lesley A.Stark*, 2019
  • ZAP-70 Shapes the Immune Microenvironment in B Cell Malignancies., Jingyu Chen; Andrew Moore; Ingo Ringshausen*, 2020
Cancer Treatment Prognosis Molecular Mechanisms Hematological Tumor Development Drug Resistance

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.